Insider Transactions in Q1 2022 at Oncternal Therapeutics, Inc. (ONCT)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 28
2022
|
Richard G Vincent Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+2.76%
|
$2,500
$1.4 P/Share
|
|
Mar 25
2022
|
Richard G Vincent Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,497
+0.95%
|
$2,497
$1.47 P/Share
|
|
Mar 24
2022
|
Richard G Vincent Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
3
+0.0%
|
$3
$1.45 P/Share
|
|
Jan 28
2022
|
Chase C. Leavitt General Counsel/Secretary |
BUY
Open market or private purchase
|
Direct |
5,000
+10.03%
|
$5,000
$1.63 P/Share
|
|
Jan 28
2022
|
Richard G Vincent Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,500
+2.92%
|
$2,500
$1.65 P/Share
|
|
Jan 27
2022
|
James B Breitmeyer Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
25,000
+34.94%
|
$25,000
$1.68 P/Share
|
|
Jan 27
2022
|
Salim Yazji Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+12.96%
|
$10,000
$1.69 P/Share
|
|
Jan 27
2022
|
Chase C. Leavitt General Counsel/Secretary |
BUY
Open market or private purchase
|
Direct |
8,500
+17.57%
|
$8,500
$1.78 P/Share
|
|
Jan 27
2022
|
Richard G Vincent Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+6.02%
|
$10,000
$1.75 P/Share
|
|
Jan 03
2022
|
Richard G Vincent Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,867
+29.71%
|
-
|
|
Jan 03
2022
|
Gunnar F. Kaufmann Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
29,867
+50.0%
|
-
|
|
Jan 03
2022
|
Chase C. Leavitt General Counsel/Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
29,867
+48.78%
|
-
|
|
Jan 03
2022
|
James B Breitmeyer Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
6,793
+50.0%
|
-
|
|
Jan 03
2022
|
James B Breitmeyer Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
128,557
+25.07%
|
-
|
|
Jan 03
2022
|
Salim Yazji Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
57,137
+50.0%
|
-
|
|
Jan 03
2022
|
Rajesh Krishnan CTO/CSO |
BUY
Grant, award, or other acquisition
|
Direct |
29,867
+50.0%
|
-
|